Study analysis · Turkish Journal of Clinics and Laboratory · 2026
Your cholesterol number at the hospital may miss the bigger picture — a simple age-times-LDL score tracked complex heart blockages better than standard lipids.
In people hospitalized with acute coronary syndrome, multiplying age by LDL cholesterol was moderately linked to more complex heart artery blockages, but this doesn't prove cause and effect.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study took a snapshot of people in the hospital with heart problems and checked if a number based on their age and cholesterol was linked to more complicated blockages in their heart arteries. It found a connection, but because it's just one snapshot, it can't prove that the cholesterol number caused the blockages.
What’s the bottom line?
This study looked at whether a measure called age-multiplied LDL cholesterol burden (AM-LDL) is linked to more complex coronary artery disease in people with acute coronary syndrome. They studied 208 patients and found that higher AM-LDL was associated with more complex blockages in the heart arteries.
How strong is this study?
The study looked at 208 people and used several math tests to check the link, which is good. But it was done at only one hospital and we only have a short summary, so we need more detailed and longer studies to be sure the results are reliable.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
16 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=208)+12.9/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. Cross-sectional design with no temporal sequence, potential confounding, and abstract-only data. Cannot determine whether AM-LDL precedes or causes coronary complexity.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information was provided in the abstract, so potential conflicts cannot be assessed.
Only an abstract was provided; it contains no author affiliations, competing interests declaration, or funding statement. Therefore, conflict of interest and bias risk cannot be determined from the available text.
Key takeaways
- 01
AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman's ρ = 0.593, p < 0.001).
- 02
Each 1-standard deviation increase in AM-LDL was linked to higher odds of high coronary complexity (SYNTAX ≥23), but the odds ratio and absolute risk increase were not reported.
- 03
Conventional lipid parameters had weaker associations.
- 04
The study found a link between AM-LDL and coronary complexity, but it did not report how much the absolute risk of high complexity increases with higher AM-LDL.
- 05
So we can't say how many extra cases of high complexity would occur per 1,000 people.
Practical takeaways
If you discuss cholesterol with a clinician, consider asking about your cumulative LDL exposure over time, not just your most recent LDL reading.
This study is observational, retrospective, single-centre, and abstract-only. AM-LDL is a research tool, not a proven clinical decision-maker. No absolute risk increase was reported.
low confidenceDon’t assume a single normal admission LDL completely rules out complex coronary artery disease in the setting of acute coronary syndrome.
The study shows correlation, not causation. It does not prove that lowering AM-LDL prevents complex blockages, and full methodology could not be verified.
low confidenceWhy this study matters
Age × LDL: A Simple Cumulative Cholesterol Score
In 208 consecutive ACS patients undergoing coronary angiography, age-multiplied LDL cholesterol burden (AM-LDL) was calculated as age in years multiplied by admission LDL-C in mg/dL. AM-LDL showed a moderate positive correlation with the SYNTAX score (Spearman’s ρ = 0.593, p < 0.001), a measure of coronary anatomical complexity. Conventional lipid parameters showed weaker or inconsistent associations.
Most people think one cholesterol test tells the whole story. This suggests a lifetime-exposure math trick may better reflect artery blockage complexity.
Linear Dose–Response, No Threshold
Restricted cubic spline analysis demonstrated a linear dose–response relationship between AM-LDL and SYNTAX-defined coronary complexity. There was no evidence of a threshold effect, meaning complexity increased steadily across the AM-LDL range rather than jumping only after a certain cutoff.
It challenges the idea that only very high cholesterol levels matter. Even gradual increases in cumulative exposure may track with more complex disease.
Higher AM-LDL Linked to Greater Odds of High Complexity
Each 1-standard deviation increase in AM-LDL was associated with increased relative odds of high coronary complexity, defined as SYNTAX ≥23. However, the abstract does not report the exact odds ratio or the absolute risk increase, so the size of the association in absolute terms is unknown.
This is the kind of headline number people want, but the missing odds ratio and absolute risk mean we can’t say how many extra people would be affected.
Conventional Lipids Weaker Than Cumulative Burden
In multivariable analyses, higher AM-LDL remained independently associated with greater coronary complexity after adjustment, while conventional lipid parameters showed weaker or inconsistent associations with the SYNTAX score. This supports the idea that cumulative atherogenic exposure may explain more than admission lipid levels alone.
Many patients are reassured by a single normal cholesterol result. This study suggests that may not capture lifetime risk.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at whether a measure called age-multiplied LDL cholesterol burden (AM-LDL) is linked to more complex coronary artery disease in people with acute coronary syndrome. They studied 208 patients and found that higher AM-LDL was associated with more complex blockages in the heart arteries.
Research results
AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman's ρ = 0.593, p < 0.001). Each 1-standard deviation increase in AM-LDL was linked to higher odds of high coronary complexity (SYNTAX ≥23), but the odds ratio and absolute risk increase were not reported. Conventional lipid parameters had weaker associations.
What this means - more context
The study found a link between AM-LDL and coronary complexity, but it did not report how much the absolute risk of high complexity increases with higher AM-LDL. So we can't say how many extra cases of high complexity would occur per 1,000 people.
To investigate the association between age-multiplied LDL cholesterol burden (AM-LDL) and coronary anatomical complexity assessed by the SYNTAX score in patients with acute coronary syndrome (ACS), and to compare its explanatory value with conventional lipid parameters.
In 208 consecutive ACS patients undergoing coronary angiography, AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman’s ρ = 0.593, p < 0.001). Higher AM-LDL was independently associated with greater coronary complexity in multivariable analyses, and each 1-standard deviation increase in AM-LDL was linked to increased odds of high coronary complexity (SYNTAX ≥23). Restricted cubic spline analysis demonstrated a linear dose–response relationship. Conventional lipid parameters showed weaker or inconsistent associations. The absolute risk increase was not reported.
Methods Used
Retrospective, single-centre study of 208 consecutive ACS patients who underwent coronary angiography. AM-LDL was calculated as age (years) multiplied by admission LDL-C (mg/dL). Coronary anatomical complexity was quantified using the SYNTAX score. Associations were evaluated using correlation analysis, multivariable linear and logistic regression, quartile-based analyses, and restricted cubic spline regression. Incremental predictive performance was assessed using receiver operating characteristic analysis.
Main Finding
AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman’s ρ = 0.593, p < 0.001). In multivariable analyses, higher AM-LDL was independently associated with greater coronary complexity. Each 1-standard deviation increase in AM-LDL was associated with increased odds of high coronary complexity (SYNTAX ≥23), but the odds ratio and absolute risk increase were not reported in the abstract. Conventional lipid parameters showed weaker or inconsistent associations.
Confidence Level
Limited - based on abstract only, full methodology not available.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Retrospective single-centre design
- •Absolute risk not reported
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Practical Takeaways
If you discuss cholesterol with a clinician, consider asking about your cumulative LDL exposure over time, not just your most recent LDL reading.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study took a snapshot of people in the hospital with heart problems and checked if a number based on their age and cholesterol was linked to more complicated blockages in their heart arteries. It found a connection, but because it's just one snapshot, it can't prove that the cholesterol number caused the blockages.
Strengths
- Sample size of 208 patients
- Use of multiple statistical methods including multivariable regression and restricted cubic spline
- Adjustment for potential confounders in multivariable models
Weaknesses
- Full methodology not available - based on abstract only
- Cross-sectional design cannot establish causality
- Single-center retrospective design
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at whether a measure called age-multiplied LDL cholesterol burden (AM-LDL) is linked to more complex coronary artery disease in people with acute coronary syndrome. They studied 208 patients and found that higher AM-LDL was associated with more complex blockages in the heart arteries.
Research results
AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman's ρ = 0.593, p < 0.001). Each 1-standard deviation increase in AM-LDL was linked to higher odds of high coronary complexity (SYNTAX ≥23), but the odds ratio and absolute risk increase were not reported. Conventional lipid parameters had weaker associations.
What this means - more context
The study found a link between AM-LDL and coronary complexity, but it did not report how much the absolute risk of high complexity increases with higher AM-LDL. So we can't say how many extra cases of high complexity would occur per 1,000 people.
To investigate the association between age-multiplied LDL cholesterol burden (AM-LDL) and coronary anatomical complexity assessed by the SYNTAX score in patients with acute coronary syndrome (ACS), and to compare its explanatory value with conventional lipid parameters.
In 208 consecutive ACS patients undergoing coronary angiography, AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman’s ρ = 0.593, p < 0.001). Higher AM-LDL was independently associated with greater coronary complexity in multivariable analyses, and each 1-standard deviation increase in AM-LDL was linked to increased odds of high coronary complexity (SYNTAX ≥23). Restricted cubic spline analysis demonstrated a linear dose–response relationship. Conventional lipid parameters showed weaker or inconsistent associations. The absolute risk increase was not reported.
Methods Used
Retrospective, single-centre study of 208 consecutive ACS patients who underwent coronary angiography. AM-LDL was calculated as age (years) multiplied by admission LDL-C (mg/dL). Coronary anatomical complexity was quantified using the SYNTAX score. Associations were evaluated using correlation analysis, multivariable linear and logistic regression, quartile-based analyses, and restricted cubic spline regression. Incremental predictive performance was assessed using receiver operating characteristic analysis.
Main Finding
AM-LDL showed a moderate positive correlation with SYNTAX score (Spearman’s ρ = 0.593, p < 0.001). In multivariable analyses, higher AM-LDL was independently associated with greater coronary complexity. Each 1-standard deviation increase in AM-LDL was associated with increased odds of high coronary complexity (SYNTAX ≥23), but the odds ratio and absolute risk increase were not reported in the abstract. Conventional lipid parameters showed weaker or inconsistent associations.
Confidence Level
Limited - based on abstract only, full methodology not available.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Retrospective single-centre design
- •Absolute risk not reported
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Practical Takeaways
If you discuss cholesterol with a clinician, consider asking about your cumulative LDL exposure over time, not just your most recent LDL reading.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study took a snapshot of people in the hospital with heart problems and checked if a number based on their age and cholesterol was linked to more complicated blockages in their heart arteries. It found a connection, but because it's just one snapshot, it can't prove that the cholesterol number caused the blockages.
Strengths
- Sample size of 208 patients
- Use of multiple statistical methods including multivariable regression and restricted cubic spline
- Adjustment for potential confounders in multivariable models
Weaknesses
- Full methodology not available - based on abstract only
- Cross-sectional design cannot establish causality
- Single-center retrospective design
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study looked at 208 people and used several math tests to check the link, which is good. But it was done at only one hospital and we only have a short summary, so we need more detailed and longer studies to be sure the results are reliable.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
16 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=208)+12.9/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 539 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. Cross-sectional design with no temporal sequence, potential confounding, and abstract-only data. Cannot determine whether AM-LDL precedes or causes coronary complexity.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information was provided in the abstract, so potential conflicts cannot be assessed.
Only an abstract was provided; it contains no author affiliations, competing interests declaration, or funding statement. Therefore, conflict of interest and bias risk cannot be determined from the available text.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Strong evidence
At least some randomized or controlled trials support this claim.
Evidence
Authored by
2 researchersIf this is your work, this is how we attribute it on Fit Body Science. Ahmet Yılmaz is listed as the lead author.